On November 26, 2021, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) 2 convened to assess B.1.1.529. On November 25, 2021, the United Kingdom Health Security Agency designated B.1.1.529 as a Variant Under Monitoring (VUI-21-NOV-01) 1.
A few countries, including the United States, have reported cases in individuals without travel history to southern Africa. The Omicron variant has also been detected in travel-related cases in several European countries, as well as Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, and the United Kingdom. A second case was reported on Decemin a person with no international travel history who also attended a convention in the days preceding symptom onset. On December 1, 2021, the first case attributed to B.1.1.529 was reported in the United States in a person who returned from travel to South Africa. South Africa has since detected B.1.1.529 in specimens collected on November 8, 2021.
B.1.1.529 was first detected in specimens collected on Novemin Botswana and on Novemin South Africa. On November 24, 2021, South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World Health Organization (WHO).
0 kommentar(er)
